https://www.selleckchem.com/pr....oducts/Temsirolimus.
Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting more than 10 million patients worldwide. Despite increasing improvements in disease management, a huge medical need still exists as its relentless progression cannot be delayed by current treatments. Therefore, scientists, clinicians, and pharmaceutical companies are hunting new drugs with 'disease-modifying' properties. This review concentrates on new therapeutics - excluding cell and gene therapies - under investigation for PD with 'disease-mo
Like
Comment
Share
